Viewing Study NCT00860457


Ignite Creation Date: 2025-12-24 @ 6:57 PM
Ignite Modification Date: 2026-04-15 @ 3:28 AM
Study NCT ID: NCT00860457
Status: COMPLETED
Last Update Posted: 2018-11-21
First Post: 2009-03-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocytic Leukemia (CLL)
Sponsor: Georgetown University
Organization: